The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Fashion does not exist in a bubble — it reflects the wider culture (for better or worse) and this was clearly evident on the ...

His son Dr Jack Mosley, a GP registrar, who researched GLP-1 drug brands including Ozempic, Wegovy, Mounjaro and Zepbound ...

The National Institutes of Health focuses on nucleotides, not narratives—but both must be an essential part of its mission.

Nvidia shares have been under pressure since late January, when the release of a lower cost artificial intelligence (AI) ...

Cooler February inflation doesn’t mean Fed will lower rates, promising obesity drug could challenge Novo Nordisk and Eli ...

A new analysis from Mybanker shows that men and women are still not equal when it comes to personal finances. Women earn less, save less for retirement, invest less often, and are less involved in ...

The number of non-Western immigrants in employment has never been higher, and the employment gap between immigrants and Danes is now the lowest ever. The development has benefited rural municipalities ...

Step right up, ladies and gentlemen, and welcome to the hottest new spot in town: The Weight-Loss Casino! Here, you don’t ...

The Arizona senator said his Tesla is a “rolling billboard for a man dismantling our government and hurting people.” ...

John Krafcik, the former CEO of the robotaxi company Waymo from 2015-2021, knows a thing or two about the driverless vehicle ...